KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Expedia (EXPE) Research & Development (2016 - 2025)

Expedia (EXPE) has disclosed Research & Development for 17 consecutive years, with $322.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development changed 0.0% to $322.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, down 2.82% year-over-year, with the annual reading at $1.3 billion for FY2025, 2.82% down from the prior year.
  • Research & Development for Q4 2025 was $322.0 million at Expedia, up from $310.0 million in the prior quarter.
  • The five-year high for Research & Development was $357.0 million in Q4 2023, with the low at $247.0 million in Q1 2021.
  • Average Research & Development over 5 years is $310.2 million, with a median of $318.5 million recorded in 2022.
  • The sharpest move saw Research & Development dropped 21.59% in 2021, then grew 21.13% in 2023.
  • Over 5 years, Research & Development stood at $274.0 million in 2021, then grew by 15.69% to $317.0 million in 2022, then increased by 12.62% to $357.0 million in 2023, then dropped by 9.8% to $322.0 million in 2024, then changed by 0.0% to $322.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $322.0 million, $310.0 million, and $325.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.